Financial-condition grades for SEC filers
Company Report · as of Oct 9, 2026
|
| Anteris Technologies Global Corp.AVR · healthcare | |
|---|---|
| Grade | Nonecomputable_factors_below_threshold: 5 of 14 inputs computable; 7 are required |
| Reliability | 0.83 AUCfailure model, filers with $12.5M to $120M assets; 95% interval 0.79 to 0.86; 201 events, 2020 to 2025 |
| Peer failure rate | 1.07% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025 |
| Size band | $12.5M to $120M assetstotal assets $23.0M[1] |
| Standard universe | insiderevenue above $1M and assets above $10M[1-2] |
| Warnings | dilution, thin datanot computable: fortress balance sheet |
| Inputs computable | 5 of 14 |
| Graded from | filings received through Feb 26, 2026225 days before the rescan; every figure keyed to the SEC receipt date |
| Last close | $6.632026-10-08; market equity $646.1M; iex feed |
| Price used in grade | None |
| Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date. Open this report as it stood on | ||||||||||||
Each date opens the report as it stood on that rescan. |
Business, in the company's words. Opening of Item 1 of the 10-K received Feb 26, 2026; the document on sec.gov.
Anteris is a structural heart company dedicated to revolutionizing cardiac care by pioneering science-driven and measurable advancements to restore heart valve patients to healthy function. Our lead product, the DurAVR® THV System, was designed in collaboration with the world’s leading interventional cardiologists and cardiac surgeons to treat aortic stenosis — a potentially life-threatening condition resulting from a narrowing of the aortic valve. The balloon-expandable DurAVR® THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow.
7 checks ran; none of them enters the letter. The checks are listed on the warnings screen.
Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.
| Input | Percentile, 0 to 100 | Value | Source | Peer median | Percentile | Peers | Period end |
|---|---|---|---|---|---|---|---|
| Profitability, sleeve percentile 81.9 | |||||||
| Gross profitability | 5.8% | [1-2,5] | 32.2% | 81.9 | 372 | 2025-12-31 | |
| Return on invested capital | not computable | 9.3% | |||||
| one or more required annual facts are missing | |||||||
| Accruals ratio | not computable | (6.6%) | |||||
| a prior annual assets observation is required | |||||||
| Gross margin stability, five years | not computable | 2.8 pts | |||||
| five annual gross margins are required; found 1 | |||||||
| Solvency, sleeve percentile 72.7 | |||||||
| Twelve-month failure probability | 0.05% | 0.07% | 32.8 | 248 | 2026-06-30 | ||
| Altman Z double-prime | (81.59) | [1,6-11] | (0.31) | 93.2 | 756 | 2025-12-31 | |
| Net debt to EBITDA | not computable | 1.82x | |||||
| one or more required annual facts are missing | |||||||
| Interest coverage | not computable | (4.51x) | |||||
| one or more required annual facts are missing | |||||||
| Current ratio | 0.73x | [6-7] | 2.96x | 92.1 | 839 | 2025-12-31 | |
| Growth and financing, sleeve percentile 88.6 | |||||||
| Revenue growth, three-year compound | not computable | 10.0% | |||||
| four annual observations are required; found 1 | |||||||
| Free cash flow growth, three-year compound | not computable | 10.9% | |||||
| four consecutive annual FCF observations are required; found 1 | |||||||
| Reinvestment rate | not computable | 37.1% | |||||
| a prior annual working-capital observation is required | |||||||
| Asset growth, three years | not computable | 2.1% | |||||
| four annual observations are required; found 1 | |||||||
| Net share issuance, one year | 169.6% | [3-4] | 2.5% | 88.6 | 634 | 2026-02-25 | |
Gross profitability. Revenue less cost of goods sold, over total assets.
Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.
Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.
Twelve-month failure probability. CHS model; lower is stronger.
Net debt to EBITDA. Lower is stronger.
Net share issuance, one year. Split-adjusted; lower is stronger.
Market measures at the 2026-10-08 close. None enters the grade. Percentile among graded peers with the same measure.
| Measure | Value | Peer median | Percentile | Reading |
|---|---|---|---|---|
| Twelve-month price change, skipping the latest month | 91.3% | 8.0% | 86 | hotter than 86 of 100 peers |
| Distance from 52-week high | (37.3%) | (31.4%) | 40 | closer to its high than 40 of 100 peers |
| EBIT to enterprise value | (23.7%) | (1.5%) | 22 | pricier than 78 of 100 peers |
| Free cash flow yield | (12.3%) | (1.0%) | 30 | pricier than 70 of 100 peers |
| Book value to price | 0.39 | 0.28 | 60 | pricier than 40 of 100 peers |
| Sales to price | 0.00 | 0.31 | 4 | pricier than 96 of 100 peers |
| Composite equity issuance, five years | not computable | 20.3% | a share count from five years earlier is required | |
| Relative strength against the sector, log excess return | 0.44 | (0.14) | 86 | ahead of 86 of 100 peers |
Inputs: market equity $646.1M; EBIT -$93.9M; free cash flow -$79.8M; book equity $251.4M; sales $1.9M; debt $47,000; cash $249.9M[12].
Diagnostics do not feed the grade.
| Piotroski F-score: None of 9, period end 2025-12-31 | ||
|---|---|---|
| Return on assets above zero | n/a | |
| Operating cash flow above zero | -$77.8M | ✗ fail[13] |
| Return on assets improved | n/a[14] | |
| Operating cash flow exceeds net income | $16.3M | ✓ pass[13-14] |
| Long-term leverage fell | n/a[1,15] | |
| Current ratio improved | n/a[6-7] | |
| No new shares issued | 169.6% | ✗ fail[3-4] |
| Gross margin improved | n/a[2,5] | |
| Asset turnover improved | n/a[2] | |
| Cash, filings, liquidity | |
|---|---|
| Cash and equivalents | $249.9M[16] |
| Operating cash flow, four quarters | -$86.3M[13,16-20] |
| Months of runway | 34.8 |
| Late filings, two years | 0 |
| NT 10-K or NT 10-Q | |
| Days since last periodic filing | 59 |
| 10-Q received Aug 11, 2026 | |
| Median daily dollar volume | $6.6M |
| 63 sessions | |
| Days since newest grade input | 225 |
|
Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.
| # | Concept | XBRL tag | Value | Period end | Received | Form | Links |
|---|---|---|---|---|---|---|---|
| 1 | assets | us-gaap:Assets | $23.0M | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 2 | revenue | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | $1.9M | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 3 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 97,232,054 | 2026-02-25 | 2026-02-26 | 10-K | filing · viewer · series |
| 4 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 36,062,370 | 2025-04-28 | 2025-04-29 | 10-K/A | filing · viewer · series |
| 5 | cost of revenue | us-gaap:CostOfGoodsAndServicesSold | $569,000 | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 6 | current assets | us-gaap:AssetsCurrent | $15.7M | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 7 | current liabilities | us-gaap:LiabilitiesCurrent | $21.4M | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 8 | retained earnings | us-gaap:RetainedEarningsAccumulatedDeficit | -$370.5M | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 9 | operating income | us-gaap:OperatingIncomeLoss | -$93.9M | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 10 | book equity | us-gaap:StockholdersEquity | -$93,000 | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 11 | liabilities | us-gaap:Liabilities | $23.2M | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 12 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 97,458,474 | 2026-08-10 | 2026-08-11 | 10-Q | filing · viewer · series |
| 13 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$77.8M | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 14 | net income | us-gaap:NetIncomeLoss | -$94.1M | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 15 | long term debt | us-gaap:LongTermDebtAndCapitalLeaseObligations | $22,000 | 2025-12-31 | 2026-02-26 | 10-K | filing · viewer · series |
| 16 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $249.9M | 2026-06-30 | 2026-08-11 | 10-Q | filing · viewer · series |
| 17 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$49.5M | 2026-06-30 | 2026-08-11 | 10-Q | filing · viewer · series |
| 18 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$28.7M | 2026-03-31 | 2026-05-12 | 10-Q | filing · viewer · series |
| 19 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$59.3M | 2025-09-30 | 2025-11-12 | 10-Q | filing · viewer · series |
| 20 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$41.0M | 2025-06-30 | 2026-08-11 | 10-Q | filing · viewer · series |
Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.
Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.
Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.
Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.
Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.